BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 30978205)

  • 41. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Booster course of antenatal corticosteroids after preterm prelabor rupture of membranes: a double-blind randomized trial.
    Porreco R; Garite TJ; Combs CA; Maurel K; Huls CK; Baker S; Fortner KB; Longo SA; Nageotte M; Lewis D; Tran L;
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100896. PubMed ID: 36796641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antenatal corticosteroid therapy (ACT) and size at birth: A population-based analysis using the Finnish Medical Birth Register.
    Rodriguez A; Wang Y; Ali Khan A; Cartwright R; Gissler M; Järvelin MR
    PLoS Med; 2019 Feb; 16(2):e1002746. PubMed ID: 30807570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes.
    Battarbee AN; Ros ST; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Andrews W; Saade G; Sadovsky Y; Reddy UM; Varner MW; Manuck TA;
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100077. PubMed ID: 32905377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes.
    Gulersen M; Gyamfi-Bannerman C; Greenman M; Lenchner E; Rochelson B; Bornstein E
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100426. PubMed ID: 34153514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health.
    Vogel JP; Souza JP; Gülmezoglu AM; Mori R; Lumbiganon P; Qureshi Z; Carroli G; Laopaiboon M; Fawole B; Ganchimeg T; Zhang J; Torloni MR; Bohren M; Temmerman M;
    Lancet; 2014 Nov; 384(9957):1869-1877. PubMed ID: 25128271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage.
    Crowther CA; Crosby DD; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000164. PubMed ID: 20091502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018.
    Corsi DJ; Hsu H; Fell DB; Wen SW; Walker M
    JAMA Netw Open; 2020 Jul; 3(7):e208256. PubMed ID: 32725246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis.
    Blankenship SA; Brown KE; Simon LE; Stout MJ; Tuuli MG
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100215. PubMed ID: 33345924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Outcomes of Multiple versus a Single Course of Antenatal Steroids: A Systematic Review.
    Ninan K; Liyanage SK; Murphy KE; Asztalos EV; McDonald SD
    Am J Perinatol; 2024 Mar; 41(4):395-404. PubMed ID: 36724821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
    Hoffman MK; Goudar SS; Kodkany BS; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Garces A; Krebs NF; Jessani S; Zehra F; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Goco N; Hemingway-Foday J; Moore J; Nolen TL; McClure EM; Koso-Thomas M; Miodovnik M; Silver R; Derman RJ;
    Lancet; 2020 Jan; 395(10220):285-293. PubMed ID: 31982074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol.
    Stewart LA; Simmonds M; Duley L; Dietz KC; Harden M; Hodkinson A; Llewellyn A; Sharif S; Walker R; Wright K;
    Syst Rev; 2017 Nov; 6(1):235. PubMed ID: 29183399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth.
    Brownfoot FC; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006764. PubMed ID: 18843729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
    Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids.
    Kearsey EOR; Been JV; Souter VL; Stock SJ
    Am J Obstet Gynecol; 2022 Aug; 227(2):280.e1-280.e15. PubMed ID: 35341727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study.
    Avalos LA; Adams SR; Alexeeff SE; Oberman NR; Does MB; Ansley D; Goler N; Padon AA; Silver LD; Young-Wolff KC
    Am J Obstet Gynecol; 2024 Jul; 231(1):132.e1-132.e13. PubMed ID: 38029850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of antenatal corticosteroids prior to preterm birth in four South East Asian countries within the SEA-ORCHID project.
    Pattanittum P; Ewens MR; Laopaiboon M; Lumbiganon P; McDonald SJ; Crowther CA;
    BMC Pregnancy Childbirth; 2008 Oct; 8():47. PubMed ID: 18925968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial.
    Althabe F; Belizán JM; McClure EM; Hemingway-Foday J; Berrueta M; Mazzoni A; Ciganda A; Goudar SS; Kodkany BS; Mahantshetti NS; Dhaded SM; Katageri GM; Metgud MC; Joshi AM; Bellad MB; Honnungar NV; Derman RJ; Saleem S; Pasha O; Ali S; Hasnain F; Goldenberg RL; Esamai F; Nyongesa P; Ayunga S; Liechty EA; Garces AL; Figueroa L; Hambidge KM; Krebs NF; Patel A; Bhandarkar A; Waikar M; Hibberd PL; Chomba E; Carlo WA; Mwiche A; Chiwila M; Manasyan A; Pineda S; Meleth S; Thorsten V; Stolka K; Wallace DD; Koso-Thomas M; Jobe AH; Buekens PM
    Lancet; 2015 Feb; 385(9968):629-639. PubMed ID: 25458726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center.
    Badreldin N; Willert GG; Henricks AA; Peaceman A; Caldarelli LA; Yee LM
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100076. PubMed ID: 32944712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial.
    Hofer OJ; Harding JE; Tran T; Crowther CA
    PLoS One; 2022; 17(2):e0263927. PubMed ID: 35192656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.